ML
Mu-Chun Li
Academia Sinica, National Health Research Institutes, National Tsing Hua University, University of Southampton, National Taiwan Normal University
Research areas: Pharmacology, Toxicology and Pharmaceutics · Drug Discovery · Computational Drug Discovery Methods · Synthesis and biological activity · Enzyme function and inhibition
0000-0002-3432-1190
Employment
-
Academia Sinica Postdoctoral fellow2021 - 2024
-
National Health Research Institutes Research assistant2012 - 2014
Education
- 2014 - 2021
-
University of Southampton MSc in Research2010 - 2011
- 2005 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (9)
- Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure‐Based Virtual Screening Save
- Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment Save
- Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer Save
- A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies Save
- Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization Save
- Mimicking H3 Substrate Arginine in the Design of G9a Lysine Methyltransferase Inhibitors for Cancer Therapy: A Computational Study for Structure-Based Drug Design Save
- Tumor‐agnostic inhibitors in oncology: A new phase for precision medicine Save
- Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors Save
- Design of drug-like hepsin inhibitors against prostate cancer and kidney stones Save